STEVENSON, Md., Nov. 08, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Navient Corporation (NASDAQ:NAVI) (“Navient” or the “Company”) securities during the period between February 25, 2016, and October 4, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until December 15, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Navient securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company engaged in deceptive practices to facilitate the origination of subprime loans and committed unfair and deceptive acts by steering student borrowers into payment plans that postponed bills and allowed interest to accumulate.
According to the complaint, following an October 5, 2017 filing of a lawsuit by Pennsylvania’s Attorney General against Navient and its subsidiary Navient Solutions, LLC, alleging widespread abuses in Navient’s student loan origination and servicing segments, as well as deceptive lending practices, the value of Navient shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Navient securities purchased on or after February 25, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/casesandinvestigations.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
FTC Questions Apple News Over Alleged Bias Against Conservative Media
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 



